Aurion Biotech is a clinical stage biotech company, developing a transformational platform of advanced therapies to cure blindness. Our first candidate is for the treatment of corneal endothelial disease, and one of the first clinically validated cell therapies for corneal care.
Location: United States, Washington, Seattle
Member count: 11-50
Total raised: $120M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | Visionary ... | visionaryv... |
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 16.04.2022 | - | $120M | - | finsmes.co... |
Mentions in press and media 7
| Date | Title | Description | Category | Author | Source |
| 07.11.2022 | Tech Moves... | Chris Beaudoin, the incoming c... | - | Charlotte ... | geekwire.c... |
| 18.04.2022 | Digital he... | Carbon Health unveils diabetes... | - | Steven Loe... | vator.tv/n... |
| 16.04.2022 | Aurion Bio... | Aurion Biotech, a Seattle, WA,... | Japan USA | - | finsmes.co... |
| 13.04.2022 | Aurion Bio... | Aurion Biotech has raised $120... | - | - | pitchbook.... |
| 12.04.2022 | Cell thera... | Hazy vision is a symptom of co... | - | Charlotte ... | geekwire.c... |
| 12.04.2022 | Eyes on th... | Aurion Biotech is setting its ... | Biotech | - | fiercebiot... |
| - | The 24-sli... | Photo_Concepts/Getty Images Th... | - | - | businessin... |